Insiders Halozyme Therapeutics, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 11:54:51 2024-05-06 am EDT			5-day change	1st Jan Change
40.64 ^USD	+1.84%		+4.95%	+10.09%

01:51pm	Bristol-Myers Gets FDA Acceptance of Review for Subcutaneous Opdivo Formulation	DJ
Apr. 25	Halozyme Therapeutics, Inc. Announces the Election of Mahesh Krishnan, M.D. to its Board of Directors	CI

Halozyme Therapeutics, Inc. Announces the Election of Mahesh Krishnan, M.D. to its Board of Directors	Apr. 25	CI
Halozyme Therapeutics Insider Sold Shares Worth $768,390, According to a Recent SEC Filing	Apr. 18	MT
Halozyme Therapeutics Insider Sold Shares Worth $839,100, According to a Recent SEC Filing	Mar. 13	MT
Halozyme Therapeutics Insider Sold Shares Worth $720,000, According to a Recent SEC Filing	Jan. 18	MT
Halozyme Therapeutics Insider Sold Shares Worth $800,262, According to a Recent SEC Filing	Dec. 14	MT
Halozyme Therapeutics Insider Sold Shares Worth $788,670, According to a Recent SEC Filing	Nov. 16	MT
Halozyme Therapeutics Insider Sold Shares Worth $365,200, According to a Recent SEC Filing	23-10-18	MT
Insider Sell: Halozyme Therapeutics	23-08-31	MT
Insider Sell: Halozyme Therapeutics	23-08-23	MT
Insider Sell: Halozyme Therapeutics	23-08-15	MT
Insider Sell: Halozyme Therapeutics	23-07-27	MT
Halozyme Therapeutics, Inc. Announces Resignation of James M. Daly as A Member of the Board of Directors	23-02-23	CI
Insider Sell: Halozyme Therapeutics	23-02-17	MT
Insider Sell: Halozyme Therapeutics	23-02-10	MT
Halozyme Therapeutics Appoints Barbara Duncan to Its Board of Directors	23-02-06	CI
Insider Sell: Halozyme Therapeutics	23-01-19	MT
Insider Sell: Halozyme Therapeutics	22-12-16	MT
Insider Sell: Halozyme Therapeutics	22-12-07	MT
Halozyme Therapeutics, Inc. Appoints Moni Miyashita to Board of Directors	22-03-15	CI
Halozyme Therapeutics, Inc. Announces Executive Changes	22-02-03	CI

No results for this search